We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sprayable Hydrogel Protects Heart from Post-Surgical Adhesions

By HospiMedica International staff writers
Posted on 29 Jun 2021
A new study describes how a novel hydrogel binds to the heart muscle to form a soft, elastic barrier that protects it from adhesions following surgery. More...


Developed at the University of California, San Diego (UCSD; USA), the hydrogel barrier is comprised of aldehyde (ALD), aminooxy (AO), and oxime crosslinked poly(ethylene glycol) (PEG), functionalized with a catechol (CAT) group, that are mixed together to form the final gel (ALD-AO-CAT). The gel has favorable mechanical properties, degradation kinetics, minimal swelling, and superior tissue retention. The material is also cytocompatible, resists cell adhesion, and reduces the severity of adhesions. It can be easily removed from tissue and dissolves after four to six weeks.

The researchers also designed a device to safely and accurately spray the hydrogel inside the surgical field during open heart surgery. The spraying device houses the hydrogel's two main components in two different chambers; each is made of PEG with different reactive groups that crosslink together to form the hydrogel. One of the solutions also includes the catechol-modified PEG to ensure it stays on the heart. The two mix as they exit the device, forming the hydrogel. The researchers described the process as akin to using two cans of spray paint, for example blue and yellow, to create a third color, green. The study was published on June 18, 2021, in Nature Communications.

“We demonstrated here that the ALD–AO–CAT hydrogel possesses mechanical characteristics and degradation kinetics that are well-suited to the conditions within the chest cavity. The material also demonstrated a lower degree of swelling that surpasses the behavior of existing products,” said senior author Professor Karen Christman, PhD, and colleagues. “Our work is an engineering solution driven by a medical problem, and now it's poised to significantly improve cardiac surgery, both for adults and children.”

Depressed fibrinolytic activity resulting from surgical trauma to the epicardium during open-heart procedures can lead to fibrous adhesion formations between the epicardium and other tissues in the chest cavity. For children born with congenital heart defects, who will experience multiple surgeries over their lifetime, and adults receiving valve replacements, mechanical circulatory support, and/or coronary artery bypass grafting, this problem is particularly relevant, as these adhesions impede heart function and severely complicate resternotomy by obstructing visibility and increasing the risk of mortality and morbidity during dissection.

Related Links:
University of California, San Diego


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Medical-Grade Display
HL2316SHTB
New
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.